X0306
4
2021-05-03
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001494875
Taylor Michael Douglas
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
1
0
0
0
Common Stock
2021-05-03
4
M
0
2354
1.89
A
2354
D
Common Stock
2021-05-03
4
M
0
5646
3.95
A
8000
D
Common Stock
2021-05-03
4
S
0
7700
46.0673
D
300
D
Common Stock
2021-05-03
4
S
0
300
46.75
D
0
D
Stock Option (Right to Buy)
1.89
2021-05-03
4
M
0
2354
0.00
D
2025-12-17
Common Stock
2354
0
D
Stock Option (Right to Buy)
3.95
2021-05-03
4
M
0
5646
0.00
D
2026-09-26
Common Stock
5646
193752
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated August 24, 2020 adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.61 to $46.58, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.65 to $46.94, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 16 equal quarterly installments at the end of each quarter following the vesting commencement date of March 1, 2014, subject to continued service through such dates.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option vests in 48 equal monthly installments at the end of each month following the vesting commencement date of July 1, 2016, subject to continued service through such dates.
/s/ Jeffrey Held, as Attorney-in-Fact
2021-05-05